Biblio Discovery — Demo Discovery Service

4 hasil untuk "Man Su"

Menampilkan 1–4 · 0,54 detik · RSS

  1. Artikel Jurnal Teks lengkap

    Occurrence of novel GII.17 and GII.21 norovirus variants in the coastal environment of South Korea in 2015

    Eung Seo Koo; Man Su Kim; Yong Seon Choi dkk.

    PLOS ONE, Vol. 12 No. 2 · 2017 · Inggris · PLOS Scopus

    Human norovirus (HNoV), a positive-sense RNA virus, is the main causative agent of acute viral gastroenteritis. Multiple pandemic variants of the genogroup II genotype 4 (GII.4) of NoV have attracted great attention from researchers worldwide. However, novel variants of GII.17 have been overtaking…

  2. Artikel Jurnal Teks lengkap

    A Drosophila Model Identifies a Critical Role for Zinc in Mineralization for Kidney Stone Disease

    Thomas Chi; Man Su Kim; Sven Lang dkk.

    PLOS ONE, Vol. 10 No. 5 · 2015 · Inggris · PLOS Scopus

    Ectopic calcification is a driving force for a variety of diseases, including kidney stones and atherosclerosis, but initiating factors remain largely unknown. Given its importance in seemingly divergent disease processes, identifying fundamental principal actors for ectopic calcification may have…

  3. Artikel Jurnal Teks lengkap

    Distribution of Human Norovirus in the Coastal Waters of South Korea

    Man Su Kim; Eung Seo Koo; Yong Seon Choi dkk.

    PLOS ONE, Vol. 11 No. 9 · 2016 · Inggris · PLOS Scopus

    The presence of human norovirus in the aquatic environment can cause outbreaks related to recreational activities and the consumption of norovirus-contaminated clams. In this study, we investigated the prevalence of norovirus genogroups I (GI) and II (GII) in the coastal aquatic environment in…

  4. Artikel Jurnal Teks lengkap

    Development and characterization of novel chimeric monoclonal antibodies for broad spectrum neutralization of rabies virus

    Pan Kyeom Kim; Sun Ju Keum; Modupe O. V. Osinubi dkk.

    PLOS ONE, Vol. 12 No. 10 · 2017 · Inggris · PLOS Scopus

    Current post-exposure prophylaxis for rabies virus infection has several limitations in terms of supply, cost, safety, and efficacy. Attempts to replace human or equine rabies immune globulins (HRIG or ERIG) have been made by several companies and institutes. We developed potent monoclonal…